# Acitretin

## Neotigason 10mg

| TAH Drug Code      | [ONEOT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONEOT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Severe forms of psoriasis & disorders of keratinization.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Psoriasis Adult Initial daily dosage， 25mg or 30 mg for 2-4 weeks. Maintenance: 25-50mg for 6-8 weeks. Maximum: 75mg/day. Keratinization disorders the lowest dose treatment is required. Less than 20 mg/day， but not more than 50 mg/day. Child: Safety and efficacy for pediatric patients have not been established. use with caution， 0.5 mg/kg. Maximum: 35mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Absolute contraindication in pregnant women. Women who may become pregnant should not receive blood from patients being treated with Neotigason. Patients undergoing Neotigason treatment are prohibited from donating blood for 3 years after completing treatment. Patients with severe liver or kidney dysfunction and those with chronically elevated blood lipid levels. Both Neotigason and tetracyclines can increase intracranial pressure， so they should not be used together. The combination of methotrexate and etretinate increases the risk of hepatitis， so methotrexate should not be used with Neotigason. Neotigason should not be combined with vitamin A or other retinoids to avoid the risk of hypervitaminosis A. Neotigason is contraindicated in patients who are allergic to this formulation (acitretin or excipients) or other retinoids. |
| Adverse Effects    | Common: Alopecia (50-75%)， Cheilitis (greater than 75%)， Disorder of nail (25-50%)， Peeling of skin (50-75%)， Pruritus (25-50%)， Xeroderma (25-50%)， Hypertriglyceridemia， Lipids outside reference range， Xerostomia (10-25%)， Arthralgia (10-25%)， Hyperesthesia (10-25%)， Paresthesia (10-25%)， Dry eye syndrome (23%)， Xerophthalmia (10-25%)， Bleeding from nose (10-25%)， Nasal mucosa dry， Rhinitis (25-50%) Serious: Myocardial infarction， Hepatotoxicity， Increased liver aminotransferase level， Pseudotumor cerebri， Ototoxicity - deafness (< 1%)， Depression (1-10%)， Capillary leak syndrome                                                                                                                                                                                                                                        |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/acitretin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

